- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00214474
Improving Diabetes Efforts Across Language and Literacy (IDEALL)
12 februari 2013 uppdaterad av: Agency for Healthcare Research and Quality (AHRQ)
The IDEALL Project (Improving Diabetes Efforts Across Language and Literacy) is a 3-arm randomized controlled trial to explore contextual factors at the patient, clinician, and organizational level of two patient self-management support strategies.
A communication technology-based intervention (automated telephone diabetes management) and an interpersonally-oriented intervention (group medical visits)will be compared to usual care for their ability to improve diabetes outcomes among vulnerable populations in 4 safety-net health centers in the University of California, San Francisco (UCSF) Collaborative Research Network.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
See above
Studietyp
Interventionell
Inskrivning (Faktisk)
339
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
California
-
San Francisco, California, Förenta staterna, 94143-1364
- Ucsf Dept of Medicine Box 1364
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- have type 2 diabetes
- have a HbA1c equal to or > 8.0%
- must speak English, Spanish, or Cantonese.
Exclusion Criteria:
- Dementia
- Psychosis/Schizophrenia
- End Stage Renal Disease
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: ATSM Intervention
ATSM Intervention: Automated Telephone Self-Management Support
|
Participants randomized to ATSM Intervention received weekly, automated (pre-recorded) telephone calls over 39 weeks (9 months).
Patient responses triggered either immediate, automated health education messages and/or subsequent nurse phone follow-up.
Andra namn:
|
Aktiv komparator: GMV Intervention
GMV Intervention: Group Medical Visits
|
GMV Intervention involved 90-minute monthly sessions over 9 months, involving 6-10 participants, co-facilitated by a primary care physician and health educator.
Andra namn:
|
Inget ingripande: Usual Care
Usual Care: Standard care for diabetic patients
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Changes in Diabetes Self-management Behaviors as Measured by Summary of Diabetes Self-Care Activities (SDSCA) Scale
Tidsram: Baseline and 1 year
|
The Summary of Diabetes Self-Care Activities (SDSCA) Measure is a brief self-report questionnaire on diabetes self-management behaviors.
The questionnaire assesses the frequency with which a patient followed a diabetes routine over the prior 7 days in five domains: diet, exercise, blood-glucose testing, foot care, and medication adherence.
Based on SDSCA measure's author's recommendations, two separate scores can be derived: a Diabetes Self-management Behaviors score and a Self-reported Medication Adherence score.
The Diabetes Self-management Behaviors score is used in this study.
For this score, all items pertaining to diet, exercise, blood glucose testing, and foot care are averaged.
The result is an average score between 0 and 7 with higher score indicating better diabetes self-management behavior.
Change is calculated as 1-year score minus baseline score.
|
Baseline and 1 year
|
Changes in Minutes of Moderate Physical Activity
Tidsram: Baseline and 1 year
|
A measure of patients' physical activity is ascertained by asking patients the following question: "In the last 7 days, how many total minutes or hours did you do physical activity?
Like walking, house cleaning or gardening."
Number of minutes may range from 0 to 10080, with greater number of minutes indicating more physical activity.
|
Baseline and 1 year
|
Changes in Minutes of Vigorous Exercise
Tidsram: Baseline and 1 year
|
A measure of patients' vigorous exercise is ascertained by asking patients the following question: "In the last 7 days, how many total minutes or hours did you do the kind of exercise that makes you breathe hard, such as swimming, walking fast, or biking?"
Number of minutes may range from 0 to 10080, with greater number of minutes indicating more vigorous exercise.
|
Baseline and 1 year
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Changes in Patient Assessment of Chronic Illness Care (PACIC)
Tidsram: Baseline and 1 year
|
The Patient Assessment of Chronic Illness Care (PACIC) is a 20-item patient report instrument that measures patients' perspectives on the structure of their care and collects patient reports on the extent to which they have received specific clinical services and actions during the past year that are aligned with the Chronic Care Model.
The scale is intended to assess the receipt of care that is patient-centered, proactive, planned and includes collaborative goal setting, problem-solving and follow-up support.
Each instrument item is scored on a 5-point scale ranging from 1 to 5 with higher score indicating better care.
Scores are transformed to a 100-point scale and averaged across all items to create a total scale score.
Change is calculated as 1-year score minus baseline score.
|
Baseline and 1 year
|
Changes in Diabetes Self-efficacy as Measured by Diabetes Quality Improvement Project's Patient Self-Management Scale
Tidsram: Baseline and 1 year
|
The Patient Self-Management Scale was derived from a questionnaire used in the Diabetes Quality Improvement Project.
The scale is designed to reflect patients' assessment of their ability to manage aspects of diabetes self-care in 5 separate areas (medication, diet, exercise, blood glucose monitoring, and foot care).
Respondents are asked how difficult over the past year has it been to follow exactly as their doctor who takes care of their diabetes suggested.
Possible scores for each scale item range from 0 to 100 with higher score indicating more self-efficacy.
Total scale score is calculated as the average across all items.
Change is calculated as 1-year score minus baseline score.
|
Baseline and 1 year
|
Changes in Interpersonal Processes of Care (IPC) Scale
Tidsram: Baseline and 1 year
|
The Interpersonal Processes of Care (IPC) captures patient reports of providers' communication over the prior year.
The scale is intended to measure patients' assessment of providers' communication within 3 broad domains: communication (e.g., lack of clarity), decision making (e.g., patient-centered decision making), and interpersonal style (e.g., friendliness).
Each instrument item is scored on a 5-point scale ranging from 1 to 5. Scores are transformed to a 100-point scale and averaged across all items to create a total scale score.
Higher total scores indicate better communication.
Change is calculated as 1-year score minus baseline score.
|
Baseline and 1 year
|
Changes in the Physical Component Summary of the SF-12 Health Survey
Tidsram: Baseline and 1 year
|
The SF-12 Health Survey (SF-12) is a 12-item short-form survey used to measure health status and monitor health outcomes.
The survey asks about various health aspects, including physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health (psychological distress and psychological well-being).
Two summary measures are derived: the Physical and the Mental Health Component Summary.
For each component summary, survey items were weighted and summed to create a summary score between 0 and 100 with higher score indicating better functioning and outcome.
Change is calculated as 1-year score minus baseline score.
|
Baseline and 1 year
|
Changes in the Mental Component Summary of the SF-12 Health Survey
Tidsram: Baseline and 1 year
|
The SF-12 Health Survey (SF-12) is a 12-item short-form survey used to measure health status and monitor health outcomes.
The survey asks about various health aspects, including physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health (psychological distress and psychological well-being).
Two summary measures are derived: the Physical and the Mental Health Component Summary.
For each component summary, survey items were weighted and summed to create a summary score between 0 and 100 with higher score indicating better functioning and outcome.
Change is calculated as 1-year score minus baseline score.
|
Baseline and 1 year
|
Number of Days Spent in Bed Due to Health Problems
Tidsram: 1 year
|
A measure of patients' functional status is ascertained by asking patients the following question: "In the last 30 days, how many days did your health keep you in bed all or most of the day?" Number of days may range from 0 to 30, with lower number of days indicating better functional status.
|
1 year
|
Proportion of Patients Reporting Diabetes Interference of Normal Daily Activities
Tidsram: 1 year
|
A measure of diabetes interference on patients is ascertained by asking patients the following question: "In the last 12 months, how often has your diabetes kept you from doing your normal daily activities, such as going to work, grocery shopping, and taking care of yourself and others?"
Responses consist of 6 possible options: "Always", "Almost Always", "Often", "Sometimes", "Almost Never", and "Never".
These responses are grouped into 2 categories, with one category consisting of "Always", "Almost Always", and "Often" responses while the other category consists of the remaining responses.
The proportion of patients reporting diabetes interference is the number of patients in the first category divided by the number of patients in the 2 categories combined.
|
1 year
|
Changes in Hemoglobin A1c Levels
Tidsram: Baseline and 1 year
|
Hemoglobin A1c is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.
As the average amount of plasma glucose increases, the fraction of hemoglobin A1c increases in a predictable way.
This serves as a marker for average blood glucose levels over the previous months prior to the measurement.
Higher amounts of hemoglobin A1c indicate poorer control of blood glucose levels and have been associated with cardiovascular disease.
Change is calculated as 1-year level minus baseline level.
|
Baseline and 1 year
|
Changes in Systolic Blood Pressure (SBP)
Tidsram: Baseline and 1 year
|
Systolic blood pressure is the pressure exerted on arteries and vessels by the heart when it contracts and pushes blood through the arteries to the rest of the body.
Change is calculated as 1-year pressure minus baseline pressure.
|
Baseline and 1 year
|
Changes in Diastolic Blood Pressure (DBP)
Tidsram: Baseline and 1 year
|
Diastolic blood pressure is the pressure exerted on the walls of the arteries and vessels in between heart beats, when the heart is relaxed and dilated, filling with blood.
Change is calculated as 1-year pressure minus baseline pressure.
|
Baseline and 1 year
|
Changes in Body Mass Index (BMI)
Tidsram: Baseline and 1 year
|
Body Mass Index (BMI) is a number calculated from a person's weight and height.
BMI is defined as the individual's body mass divided by the square of their height.
The formulae used produce a unit of measure of kg/m2.
BMI provides an indicator of body fatness.
|
Baseline and 1 year
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Dean Schillinger, MD, University of California, San Francisco
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 november 2002
Primärt slutförande (Faktisk)
1 november 2005
Avslutad studie (Faktisk)
1 november 2005
Studieregistreringsdatum
Först inskickad
19 september 2005
Först inskickad som uppfyllde QC-kriterierna
19 september 2005
Första postat (Uppskatta)
22 september 2005
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
13 februari 2013
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
12 februari 2013
Senast verifierad
1 februari 2013
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 1R21HS014864-01 (U.S.A. AHRQ-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på ATSM Intervention
-
Institut Cancerologie de l'OuestFondation ARCAktiv, inte rekryterande
-
Collaborative Medicinal Development Pty LimitedOkänd
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Avslutad
-
Washington University School of MedicineIndragenKarcinom, icke-småcellig lunga
-
Third Military Medical UniversityOkänd
-
Third Military Medical UniversityOkändIrritabel tarmsyndromKina
-
Collaborative Medicinal Development Pty LimitedAktiv, inte rekryterande
-
Collaborative Medicinal Development Pty LimitedAvslutad
-
Collaborative Medicinal Development Pty LimitedAvslutadMotorneuronsjuka | Amyotrofisk lateral sklerosAustralien
-
Collaborative Medicinal Development Pty LimitedAvslutadAmyotrofisk lateral sklerosAustralien